Trial intelligence / Profile preview

Safety and bioavailability of Tirosint in hypothyroid thyroidectomized adults

2012-003677-25Phase 4Terminated

Sponsor
IBSA Group
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of levothyroxine in hypothyroidism (2 arms), sponsored by IBSA Group. Primary endpoint: Primary: absorption pattern based on circulating total T4. Started Dec 2012; status: terminated.

02

Drugs

levothyroxine
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on 2012-003677-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003677-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call